In Medscape: When it comes to clinical trials, “more, more, more is not always better,” said [Michelle] Tregear, director of […]
“Changes to FDA warnings and labeling should be grounded in rigorous, contemporary evidence—not post-hoc or subgroup re-analyses of older trials. ”
“As a breast cancer survivor, [Visco] turned pain into purpose, changed the landscape of breast cancer advocacy, and has become a powerful symbol of hope for the nation.”
Nicole Levins, communications director
nlevins@stopbreastcancer.org
In Medscape: When it comes to clinical trials, “more, more, more is not always better,” said [Michelle] Tregear, director of […]
NBCC Leaders Plan Full-Court Press During August Congressional Recess NBCC grassroots leaders will be out in full force during the […]
In The Lancet: “Oncology needs a recalibrated approach that is more patient centred and prioritises equitable cancer care. An approach […]
NBCC President Fran Visco writing in The Cancer Letter: “It is rare, but there are times some of us are […]
NBCC Remembers Dr. Susan Love NBCC mourns the loss of Dr. Susan Love, who died on July 2 after a […]
In the Washington Post: “It was Susan’s vision that really launched breast cancer advocacy,” [NBCC President Fran] Visco said. “She […]
